Rafarma and Haifa Technopark Enter Talks for Joint Venture
April 30, 2021 09:31 ET
|
RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, April 30, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce that on April 26, 2021 the company entered negotiations and formed an action plan...
Rafarma Embarks on Aggressive Global Partnerships Plan
March 04, 2021 10:55 ET
|
RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, March 04, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce its newly formulated strategies for aggressive global growth in 2021/2022. Given...
Letter To Shareholders from Chairman Ilya Shpurov
November 09, 2020 09:15 ET
|
RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus , Nov. 09, 2020 (GLOBE NEWSWIRE) -- November 9, 2020 (GLOBE NEWSWIRE) Rafarma Pharmaceuticals, Inc. OTC:(RAFA) shares the following letter to shareholders from Chairman Ilya Shpurov:...
Auditing Firm L J Soldinger Associates Retained for Rafarma Biocogency Merger
November 04, 2020 09:01 ET
|
RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, Nov. 04, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce that the elite Chicago auditing firm LJ Soldinger Associates...
Rafarma Closes Biocogency Merger
October 19, 2020 09:15 ET
|
RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce that it has closed the merger with BIOCOGENCY LABORATORIES. The new consolidated...
Rafarma Approves Issuance of Majority of Voting Shares to Board Chairman Ilya Shpurov
October 06, 2020 10:13 ET
|
RAFARMA PHARMACEUTICALS INC
Ljubljana, Slovenia, Oct. 06, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce approval of Ilya Shpurov receiving the majority of Preferred B shares,...
Rafarma - Biocogency Acquisition Progresses to Preparation of GAAP Financials and Form 10 Drafting for Full SEC Reporting
August 14, 2020 09:15 ET
|
RAFARMA PHARMACEUTICALS INC
Ljubljana, Slovenia, Aug. 14, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to update its shareholders on the progress of its acquisition by the R. & D. BIOCOGENCY...
Letter to Shareholders Regarding Rafarma Acquisition by R. & D. Biocogency Laboratories Inc.
August 05, 2020 09:15 ET
|
RAFARMA PHARMACEUTICALS INC
Ljubljana, Slovenia, Aug. 05, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) presents the following letter to Rafarma shareholders from CEO Vladimir Dolgolenko: To Our...
Rafarma to be Acquired by R. & D. Biocogency Laboratories Inc.
August 04, 2020 09:15 ET
|
RAFARMA PHARMACEUTICALS INC
Ljubljana, Slovenia, Aug. 04, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce that it has reached an agreement to be acquired by R. & D. Biocogency...
Rafarma Finalizes Announces New Product
June 15, 2020 10:48 ET
|
RAFARMA PHARMACEUTICALS INC
Ljubljana, Slovenia, June 15, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, (OTC:(RAFA) Inc. is happy to announce commencement of tests for its new product “HempySleep”. The product was designed...